SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Fresh ESMO oncology updates are drawing attention, including early ovarian-cancer data for Lillys investigational Sofe-M combination; traders also debate the pullback and upcoming earnings, with bullish breakout hopes countered by concerns about fading momentum and resistance.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas Phase 3 melanoma results for a personalized cancer vaccine added to Keytruda are the main focus, with the combination meeting recurrence-free and distant metastasis-free survival endpoints. Traders see the data as validation of Mercks oncology pipeline, while debating the vaccines broader potential, path to approval and commercial value against valuation concerns.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for choppy, range-bound trading, with repeated chart commentary describing consolidation. Holders see the pullback as a chance to accumulate or set up a rebound, while skeptics point to weak utility and worry about further declines.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOS is drawing attention for its steep selloff toward 52-week lows, despite reported contract wins, analyst upgrades, and past earnings beats. Traders debate whether the decline reflects an expensive valuation, insider selling, and concerns about turning demand and production growth into profitsor an overdone pullback in a defense and drone company with long-term growth prospects.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

Chinas rare-earth export restrictions and uncertain U.S.-China negotiations have renewed attention on MPs role in building a domestic mine-to-magnet supply chain. Traders remain divided: some see geopolitical and government support as a long-term tailwind, while others focus on the stocks prolonged decline and question near-term execution and demand.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Traders are focused on CVSs November 4 earnings report, with many positioning for a rebound after the stocks recent pullback and pointing to technical support. Others are wary of sellers and whether the shares can regain momentum ahead of the results.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention amid broad-market concerns about elevated rates, inflation, energy costs and a possible AI-led correction, with traders debating whether recent weakness signals deeper risk or a buying opportunity. Some favor long-term index investing and dollar-cost averaging, while others expect further volatility and declines.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is drawing attention around its earnings setup, with traders citing stronger engagement tied to the viral game Steal an Egg and analyst optimism about bookings. Bullish momentum and call positioning compete with caution about earnings volatility and the stocks history of sharp post-report moves.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Attention centers on reports that the administration is weighing temporary access to certain compounded peptides, which traders view as a potential growth opportunity for Hims; no approval is confirmed. Optimism about peptides and a possible short squeeze contrasts with frustration over repeated reversals and resistance near $30.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellias FDA-accepted BLA for lonvo-z, granted Priority Review for hereditary angioedema, is the main catalyst, with traders focused on the March 2027 decision and the therapys Phase 3 results. Bulls see a potential path toward commercialization and validation of the gene-editing platform, while bears point to cash needs, commercialization risks and volatile trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CME Group Names Jack Tobin As Next CFO Ahead Of March 2027 Leadership Transition

Equity

Longtime CME Group executive Jack Tobin will succeed Lynne Fitzpatrick as CFO when she takes over from Terry Duffy as CEO.

BlackRock Stock Rises Pre-Market: Record Inflows Drive Q4 Revenue Beat 

BlackRock’s fourth-quarter revenue rose 19% to $7 billion, well above Wall Street estimates of $6.49 billion, according to Fiscal.ai data.


5 ETFs With Big Inflows Last Week on S&P 500's Record Rally

VOO, VXUS, GLD, SPY and DYNF led ETF inflows last week as the S&P 500 hit five straight record closes.


Active ETFs Catch a Wave of Investor Interest 

BlackRock ETF Trust - iShares U.S. Equity Factor Rotation Active ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Tobin will become Deputy CFO in November 2026 and CFO in March 2027.</li><li>He has worked at CME Group since 2002 and served as Chief Accounting Officer since 2015.</li><li>In June, CME said longtime Chief Executive Terry Duffy will step down as CEO in March 2027, with Lynne Fitzpatrick taking over the role.</li></ul>CME Group Inc. (CME) on Wednesday named longtime insider Jack Tobin as its next Chief Financial Officer, succeeding current President and CFO Lynne Fitzpatrick, who takes over as the firm’s Chief Executive Officer in March next year.Tobin has more than 35 years of financial experience and joined CME Group in 2002. Since becoming Chief Accounting Officer in 2015, he has overseen accounting, corporate development and finance functions at the company.Before joining CME, Tobin worked as a principal consultant at PricewaterhouseCoopers. CME said he will continue to report to Fitzpatrick after taking over as CFO. Matthew Render, who joined CME as Deputy Chief Accounting Officer in August 2026, will succeed Tobin as Chief Accounting Officer.&nbsp;The appointments come ahead of CME’s previously announced CEO transition. In June, CME said longtime Chief Executive Terry Duffy will step down as CEO in March 2027, with Fitzpatrick taking over the role.<h2 class="st-heading-2">CME’s Agreement With EEX&nbsp;</h2>CME recently announced that the European Energy Exchange (EEX) intends to phase out its dairy business and to support the transition of its suite of indices that underpin existing futures contracts to CME Group before the end of 2027.&nbsp;CME stated that the transaction, which includes the European butter and skimmed milk powder indices, will mark CME Group's entry into the European dairy market. It also has plans to launch its own European dairy indices, futures and options in the near future.<h2 class="st-heading-2">What Retail Investors Think About CME Stock?</h2>Retail. Investor sentiment on Stocktwits surrounding <a href="https://stocktwits.com/symbol/CME">CME stock</a> remained ‘bearish’ amid ‘normal’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_09_09_222205_0a120f33bf.png" alt="Screenshot 2026-09-09 222205.png" width="817" height="450"><figcaption>CME stock retail sentiment on September 9 as of 12:45 p.m. ET | Source: Stocktwits</figcaption></figure>CME shares were trading marginally in the red on Wednesday. The stock has risen 2.2% so far this year and around 12% in the last 12 months.See Also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/chwy-stock-hits-over-1-month-low-after-flat-q2-gross-margin-overshadows-raised-outlook/cZt7IpqRJzm">CHWY Stock Hits Over 1-Month Low After Flat Q2 Gross Margin Overshadows Raised Outlook</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

CME Group Inc. (CME) on Wednesday named longtime insider Jack Tobin as its next Chief Financial Officer, succeeding current President and CFO Lynne Fitzpatrick, who takes over as the firm’s Chief Executive Officer in March next year.

CME Group Inc

iShares US Equity Factor Rotation Active ETF

Vanguard Dividend Appreciation ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$67.98
Prev Close	$68.36
Open	$67.95
Dividend Yield	N/A
50-Day Moving Average	$69.53
Beta	N/A
Avg. Volume	2.37M
PE Ratio	N/A

52-Week High	$70.91
52-Week Low	$56.18
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

DYNF Fundamentals